Jannah Theme License is not validated, Go to the theme options page to validate the license, You need a single license for each domain name.
USA

What Happened at Federal Hearings on Abortion Drugs : NPR

J. Marvin Jones Federal Building and Mary Lou Robinson United States Courthouse in Amarillo, Texas. U.S. District Judge Matthew Kaksmalik is set to decide a lawsuit regarding the abortion drug mifepristone.

Justin Rex/AP


hide caption

toggle caption

Justin Rex/AP


J. Marvin Jones Federal Building and Mary Lou Robinson United States Courthouse in Amarillo, Texas. U.S. District Judge Matthew Kaksmalik is set to decide a lawsuit regarding the abortion drug mifepristone.

Justin Rex/AP

Court officials in Amarillo, Texas, held a closely-monitored hearing this week in a federal lawsuit that could limit nationwide access to drugs used in nearly all drug-induced abortions in the United States. Record published.

There were only a few dozen members of the public and media. allowed internally Wednesday’s small court was presided over by U.S. District Judge Matthew Kaksmalik, who has long-standing ties to conservative groups. The judge heard four hours of testimony from attorneys for a coalition of anti-abortion rights groups called the Hippocratic Medical Alliance, which are challenging approval of the drug, and government attorneys representing the Food and Drug Administration.

Recording in court was also prohibited, so this transcript is the first opportunity for most members of the public to know firsthand what was said.

Kacsmaryk initially delayed announcing the timing of the hearing, he said. report To Washington Postbut released that information on Monday in response to pressure from media organizations.

A judge ultimately allowed an audio live stream of the hearing inside a federal courtroom in Dallas, but not recording, and the feed was not made public.

In 2000, the FDA approved mifepristone for use in combination with a second drug to terminate early pregnancies. Opponents of abortion have questioned the drug’s approval process. Safety record.

Kacsmaryk can order the drug to be removed from the market or take various actions. Other steps Limit it. Whatever the outcome, an appeal is widely expected.

Summarize this content to 100 words

J. Marvin Jones Federal Building and Mary Lou Robinson United States Courthouse in Amarillo, Texas. U.S. District Judge Matthew Kaksmalik is set to decide a lawsuit regarding the abortion drug mifepristone.

Justin Rex/AP

hide caption

toggle caption

Justin Rex/AP

J. Marvin Jones Federal Building and Mary Lou Robinson United States Courthouse in Amarillo, Texas. U.S. District Judge Matthew Kaksmalik is set to decide a lawsuit regarding the abortion drug mifepristone.

Justin Rex/AP

Court officials in Amarillo, Texas, held a closely-monitored hearing this week in a federal lawsuit that could limit nationwide access to drugs used in nearly all drug-induced abortions in the United States. Record published. There were only a few dozen members of the public and media. allowed internally Wednesday’s small court was presided over by U.S. District Judge Matthew Kaksmalik, who has long-standing ties to conservative groups. The judge heard four hours of testimony from attorneys for a coalition of anti-abortion rights groups called the Hippocratic Medical Alliance, which are challenging approval of the drug, and government attorneys representing the Food and Drug Administration. Recording in court was also prohibited, so this transcript is the first opportunity for most members of the public to know firsthand what was said.

Kacsmaryk initially delayed announcing the timing of the hearing, he said. report To Washington Postbut released that information on Monday in response to pressure from media organizations. A judge ultimately allowed an audio live stream of the hearing inside a federal courtroom in Dallas, but not recording, and the feed was not made public.

In 2000, the FDA approved mifepristone for use in combination with a second drug to terminate early pregnancies. Opponents of abortion have questioned the drug’s approval process. Safety record. Kacsmaryk can order the drug to be removed from the market or take various actions. Other steps Limit it. Whatever the outcome, an appeal is widely expected.

https://www.npr.org/2023/03/17/1164112268/abortion-pill-drug-hearing-amarillo-texas-federal-judge-kacsmaryk What Happened at Federal Hearings on Abortion Drugs : NPR

Back to top button